News Center

Home page

Peak Report

News reports

My "second love" with the spike"

Release time:

2020-07-22

My "Second Love" with Peak

Remember that it was 2002 5# August 8 . I first reported to Peak Pharmaceutical, and my destination was Linhai Jianfeng Haizhou Pharmaceutical Factory, a subsidiary factory of the pharmaceutical industry. At that time, Haizhou Pharmaceutical had overgrown weeds at the factory gate, and "desolation" was the first impression it gave me. In the old factory area, I only stayed for one month, and the next month I went to Du Qiao to build a new factory. Although some details can't be remembered now, the "weeding incident" that occurred that month is still impressive. At that time, the greening work in the factory was contracted by an employee, because the enterprise was facing relocation due to poor efficiency, the mentality of the employees was floating, and some managers did not dare to take care of it, so I pulled out a handful of weeds and put them on the employee's desk, forcing him to pull the weeds. Although this seemed unpleasant at the beginning, it was the so-called "no fight, no acquaintance", and later this employee became my good friend. This employee's name is Wu Shunfa. Some old employees may still remember that he is also an excellent salesman.

2002 5 to 2005 was my first working experience in Jianfeng Pharmaceutical, mainly responsible for preparing for the construction of a new factory. Those two and a half years can be described as a turbulent period for the pharmaceutical industry. From the pharmaceutical company to Haizhou Pharmaceutical, the leadership team changed several times. However, with the joint efforts of my colleagues and I, we still completed the preparation for the new factory and the relocation of equipment, and successfully passed the bulk drug GMP examination in 5 before the deadline for passing the GMP certification stipulated by the State Food and Drug Administration in 2004 . That experience meant a lot to my personal growth, and I'm always grateful for it. Although later for some reason left the peak, but in the peak of the day, left me are good memories. Although the conditions at the time of preparation were very poor, lunch was often a bowl of pickle soup in the canteen of the construction team, but when the leaders at all levels of the company came to inspect the work, they always cared about our life, so that I still miss the taste of braised three green crabs. More than ten years have passed in a flash. Although the external environment has changed greatly and the production of peak pharmaceutical preparations has developed and expanded, the development of API has returned to the starting point.

2016

, when there was another chance to return to the peak family, I decisively chose to return. Because I have been wandering outside for many years, I still can't forget the surprise of receiving a "good wife award" at the end of 2002 and the happiness of my family, as well as the careful guidance of the pharmaceutical project department to our preparatory team that year. It's the spikes that help me grow. Besides, in the more than ten years since I left the peak, the group leaders have visited me many times during the inspection and exchange of peer companies, which fully reflects the humanistic feelings of a listed company. Now, I have returned to work in Peak Pharmaceutical for more than two years. This is still the peak I am familiar with, but it is a little strange. The perfect enterprise system is not the same as that of that year. This time, as the person in charge of the pharmaceutical preparation for the establishment of the API business department, I got more help from peak managers during the investment inspection work of one and a half years. No matter the concept of leading investment and development of enterprises, or the quality of professionals, I feel deeply. In particular, the "innovative" spirit of enterprise, let me have a real experience. I understand that the slightly conservative peak in the original impression actually contains deep innovation genes. The new generation of leaders is leading the peak to rejuvenate and move towards new glory.

Now, our Jianfeng Pharmaceutical Co., Ltd. has regained its platform for the development of API business-Shanghai Beika Pharmaceutical Technology Co., Ltd., and has two Anhui factories. I am full of confidence in the future development of the API production base. Up to now, the peak has gone through

years of development. I write this article to my small partners and new colleagues now. I also use this to encourage us to contribute to the "100-year peak. (Lou Xiaohua)

More information

The company fully deploys 2018 work

On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals

2020

07-30

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise

On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.

2020

07-31

Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

< 1...38 39 40...61 > 跳转到页